Fresh analysis indicates that people who stop using blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight far faster than those who end conventional lifestyle regimens.
Published data in a major medical journal points out that while overweight people often shed substantial amounts of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"People buying such drugs need to be aware of the danger of quick weight regain when the medication is stopped," stated lead investigator Dr. Susan Jebb.
Such speed of regain means a reversion to starting weight in about one and a half years.
Analyzing Treatments
The research, which looked at dozens of trials involving over 9,000 of participants, compared the results of these new drugs with other pills.
Scientists note that people who lose weight through diet and exercise generally have a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
Explaining the Rapid Regain
Nutrition scientists suggest the mode of action of the injections is key to understanding the heightened rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Long-term administration of the hormone concentrations far above than normal might result in the body to produce less of its own natural GLP-1, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Stopping of this hormone supplement results in hunger is uncontrolled, making binge eating a significant risk."
A Lifelong Issue?
Health authorities recommend the jabs for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts argue that, considering the likelihood of relapse, the therapy might need to be long-term.
This opinion is reinforced by pharmaceutical companies, who state that the findings "highlight the chronic nature of obesity," akin to managing conditions like diabetes.
User Accounts
Users who have stopped the jabs explain a intense return of hunger.
"I experienced a trigger flipping and you're instantly starving," recalled an individual.
The struggle is exacerbated if patients have not adopted lasting lifestyle or habit modifications during treatment.
Widespread Adoption
Recent estimates show that a significant number of adults in the UK have used these injections in the last 12 months, with interest being substantial.
- Adoption is greater among females than males.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent cure and lasting health benefits hinges on integrated behavioural support.
